# Sermorelin FAQ: GHRH(1-29) Questions, Answered from the Research > Sermorelin FAQ: clear, cited answers to the most-asked questions about GHRH(1-29) — what it is, how it works, side effects, half-life, sleep, IGF-1, and how it compares to other secretagogues. Twenty-two real questions about sermorelin, each answered straight from the cited literature. ## What is sermorelin? Sermorelin (sermorelin acetate) is a synthetic 29-amino-acid peptide corresponding to the 1-29 N-terminal fragment of growth hormone-releasing hormone (GHRH) — the shortest fragment that retains full GHRH activity [4]. It binds pituitary GHRH receptors to stimulate the body's own pulsatile growth-hormone release, rather than supplying growth hormone from outside. ## What does sermorelin do to the body? It activates the GHRH receptor on anterior-pituitary somatotrophs via the cAMP/PKA pathway, prompting synthesis and pulsatile secretion of growth hormone, which in turn raises hepatic IGF-1 [4]. Because it acts upstream, somatostatin and IGF-1 feedback stay intact, so the body's natural pulsatile GH pattern is preserved rather than overridden. ## What is sermorelin used for? Its historical FDA-approved use was the diagnosis and treatment of idiopathic growth-hormone deficiency / short stature in children; that branded product (NDA 020443) was withdrawn from the US market in 2008 for commercial reasons, not safety or efficacy. In research, GHRH(1-29) and its stabilized analogs have been studied in aging, cognition, sleep, and body composition [2][6]. ## Does sermorelin work? In GH-deficient children, once-daily subcutaneous GHRH(1-29) raised first-year height velocity from about 4.1 to roughly 7-8 cm/year [1]. In healthy older men, 0.5-1 mg twice daily for 14 days produced dose-related increases in 24-hour GH and IGF-1 [2]. Anti-aging and body-composition marketing, however, outpaces the rigorous long-term evidence [5]. ## How long does it take for sermorelin to work? Pharmacokinetically, a single dose elevates serum GH for roughly three hours despite a short ~10-12 minute plasma half-life [3]. Endpoint studies measured effects over 14 days in older men [2], while cognition and body-composition GHRH-analog trials ran about 20 weeks [6] — so measurable axis changes were assessed on a weeks-to-months scale. ## What are the side effects of sermorelin? Controlled GHRH-axis studies report generally mild adverse events [6]. Because GH and IGF-1 are mitogenic, chronically raising them carries a theoretical oncologic consideration common to any GH-axis intervention [5], and long-term safety data specifically for adult anti-aging use are limited — most controlled studies ran only weeks to about 20 weeks. ## Sermorelin long term side effects nobody seems to document past the 12 week mark That gap is real. Controlled GHRH-axis trials report generally mild adverse events [6], but long-term tolerability data specifically for adult use are sparse, and an *Annals of Internal Medicine* editorial judged GH-secretagogue use for aging 'not yet ready for prime time' [5]. Most controlled studies ran weeks to about 20 weeks, so extended-duration data are thin. ## Is sermorelin effective for weight loss? There is no robust sermorelin-specific weight-loss trial evidence. The body-composition signal comes from the stabilized analog tesamorelin (visceral-fat reduction) and from GH/IGF-1 physiology; the cognition trial's 7.4% body-fat reduction used the stabilized analog, not sermorelin [6]. The literature frames this as drug-class evidence, and marketing claims outpace the rigorous data. ## Does sermorelin burn fat? In the GHRH-analog drug class, the stabilized analog tesamorelin significantly reduced visceral adipose tissue versus placebo, and pulsatile GH contributes to fasting lipolysis. These are GHRH-axis/drug-class findings [6], not sermorelin-specific fat-loss trials, and proven anti-aging body-composition benefit is not established for sermorelin itself. ## Does sermorelin build muscle? Sermorelin raises GH and IGF-1, hormones involved in muscle and body composition [2][6], and reviews discuss GH/IGF-1-axis modulation as a candidate strategy against age-related muscle loss (sarcopenia) [13][14]. Direct muscle-building efficacy data for sermorelin in healthy adults, however, are limited rather than established. ## Will sermorelin raise my IGF-1 levels? Yes — by stimulating pituitary GH release, GHRH(1-29) raises downstream hepatic IGF-1. In older men, 0.5-1 mg twice daily for 14 days produced dose-related IGF-1 increases [2], and a GHRH analog raised IGF-1 by 117% — within the physiologic range — in a controlled cognition trial [6]. ## Does sermorelin affect testosterone? Sermorelin acts on the GH/IGF-1 axis, not the gonadal axis directly. Research on GH secretagogues focused on raising serum IGF-1 and altering body composition [2][6]; the documented effect is on the somatotropic (GH/IGF-1) axis rather than on testosterone itself. ## Does sermorelin affect the brain? In a randomized trial, 20 weeks of a daily GHRH analog had a favorable effect on cognition in older adults, including those with mild cognitive impairment (P=0.03; executive function P=0.005) [6]. GHRH administration has also been shown to modulate brain neurochemistry, a correlate of its cognitive effects [6]. ## Can sermorelin or GHRH improve cognition in older adults? A randomized, double-blind, placebo-controlled trial of 152 older adults found that 20 weeks of a daily GHRH analog favorably affected cognition (P=0.03; executive function P=0.005), alongside a 117% IGF-1 increase and a 7.4% reduction in percent body fat, with mild adverse events [6]. The effect was seen in both healthy elders and those with mild cognitive impairment. ## Does sermorelin actually help with sleep, or is it waking me up instead? GHRH had sleep-promoting (slow-wave) effects in normal men, but the effect depends on the time of administration [11] and is reduced in the elderly [10]. Slow-wave sleep coincides with nocturnal GH release [12], which is the physiologic rationale for bedtime dosing — though individual experience varies and the data are population-level, not personal. ## Why is it recommended to inject sermorelin at night? Endogenous GH is secreted in pulses concentrated during slow-wave sleep, and sleep onset and slow-wave sleep are significant for nocturnal GH release [12]. Bedtime GHRH dosing leverages this physiology to align stimulation with the body's natural overnight GH surge — which is why the pediatric efficacy regimen was dosed at bedtime [1]. ## When is the best time to take sermorelin? Studies indicate GHRH's sleep-endocrine effects depend on the time of administration [11], and nocturnal GH release is tied to slow-wave sleep [12] — the basis for the commonly studied bedtime, subcutaneous regimen [1]. This is a description of research protocols and physiology, not a dosing recommendation. ## Is 3 months of sermorelin enough? Trial durations varied: 14 days in older men [2], the first year of therapy in GH-deficient children [1], and about 20 weeks in cognition/body-composition GHRH-analog studies [6]. There is no established 'sufficient duration' for adult use, and long-term data remain limited — so the literature does not define a fixed three-month endpoint. ## How does sermorelin compare to CJC-1295? Both are GHRH analogs, but sermorelin is native GHRH(1-29) with a short ~10-12 minute half-life [3], whereas CJC-1295 uses a D-Ala2 substitution and DAC (albumin-binding) technology to extend its duration to days. Sermorelin's short native half-life is exactly what motivated such longer-acting analogs [3]; the analog-development arc is surveyed in the recent reviews [14]. ## Sermorelin vs ipamorelin: what is the difference? Sermorelin is a GHRH analog acting on the pituitary GHRH receptor; ipamorelin is a growth-hormone-releasing peptide (GHRP) acting on the separate ghrelin/GHS receptor. They engage different receptors [13], which is why research-user discussions often treat them as complementary rather than equivalent, with sermorelin mimicking the GHRH signal and ipamorelin the ghrelin signal. ## How does sermorelin differ from direct HGH injections? Direct HGH supplies exogenous growth hormone; sermorelin instead stimulates the pituitary to make its own, so somatostatin and IGF-1 feedback remain intact and the natural pulsatile pattern is preserved [4]. An editorial argued this is a more physiologic approach to adult-onset GH insufficiency than recombinant GH [4]. ## Are there other peptides or applications being researched for GHRH analogs? Yes. Beyond the GH/IGF-1 axis, agonistic GHRH analogs (MR-409, MR-502) have been studied for wound healing in human fibroblasts and rodent models [7], and a 2025 review surveys GHRH-analog development across cancer, regenerative medicine, and metabolic disorders [14]. These are preclinical or computational signals [8], not approved sermorelin uses. --- A corkboard reading of the sermorelin literature, riso-clipped and red-strung — every GHRH(1-29) finding pinned to the study that measured it, the body-composition data taped where it belongs as tesamorelin, the frontier wound-healing and oncology signals stamped provisional, and the torn-open clipping where the adult-safety evidence runs out left in plain view; 'get' here means get the literature, and nothing on this board is dosed, dispensed, or sold.